Results 231 to 240 of about 35,513 (277)

Cross-Reactive NSAID Hypersensitivity: Clinical Findings From Aspirin Provocation and Alternative Drug Challenge Testing. [PDF]

Clin Transl Sci
Koh YI, Yu JE, Sim DW.
europepmc   +1 more source

Successful Pregnancy and Delivery Following Autologous Abdominal Wall Reconstruction: A Case Report and Literature Review. [PDF]

Plast Reconstr Surg Glob Open
Kitai R, Yasunaga Y, Watarai A, Suzuki S, Araki J, Katagiri H.   +5 more
europepmc   +1 more source

A Surgical Method for Oocyte Injection and CRISPR-Cas9 Mutagenesis in <i>Anolis</i> Lizards. [PDF]

Cold Spring Harb Protoc
Sabin CE, Samudra SP, Iouchmanov AL, Rittgers AL, Lauderdale JD, Menke DB.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Meloxicam

Reactions Weekly, 2020
Meloxicam, an oxicam derivative: 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2- benzothiazine-3-carboxamide 1,1-dioxide, is a nonsteroidal anti-inflammatory drug (NSAID). It is a selective inhibitor of cyclooxygenase-2 (COX-2). It is used in the management of rheumatoid arthritis, acute exacerbations of osteoarthritis, ankylosing spondylitis and ...
Nasr Y, Khalil, Khalid F, Aldosari
  +5 more sources

Meloxicam

Drugs, 1996
Meloxicam is a new nonsteroidal anti-inflammatory drug (NSAID) developed for the treatment of rheumatoid arthritis and osteoarthritis. It has greater in vitro and in vivo inhibitory action against the inducible isoform of cyclo-oxygenase (COX-2), which is implicated in the inflammatory response, than against the constitutive form of this enzyme (COX-1),
S, Noble, J A, Balfour
  +5 more sources